belimumab
gsk
['belimumab', 'lupus']
a systematic review and meta-analysis presented at #acr22 provide insight into the effects of #belimumab in patient populations with cutaneous #lupus erythematosus, with or without systemic lupus erythematosus. 
News summaries, features, Q&As and more information about advances in rheumatology by and for healthcare professionals who treat patients with rheumatic disease